Guía de Práctica Clínica sobre Cuidados Paliativos - Cedepap TV

194. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative metaanalysisof pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry.2002;159(1):5-11.195. Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomniain the regulation of long-term hypnotic drug use. Health Technol Assess. 2004;8(8):iii-68.196. Hirst A, Sloan R. Benzodiazepines and related drugs for insomnia in palliative care. CochraneDatabase Syst Rev. 2002;(4):CD003346.197. Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM Endof-LifeCare Consensus Panel. American College of Physicians - American Society of InternalMedicine. Ann Intern Med. 2000;132(3):209-18.198. Jackson KC, Lipman AG. Drug therapy for anxiety in palliative care. Cochrane DatabaseSyst Rev. 2004;(1):CD004596.199. Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety,and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006;36(1):13-34.200. Edwards AG, Hailey S, Maxwell M. Psychological interventions for women with metastaticbreast cancer. Cochrane Database Syst Rev. 2004;(2):CD004253.201. Chochinov HM, Holland JC. Handbook of psycho-oncolgy:Psycological care of the patientwith cancer. In: JC Holland and JH Rowland, editor.New York: Oxford University Press;1998.202. de SE, Jepson BA. Midazolam in terminal care. Lancet. 1988;1(8575-6):67-8.203. Carr DB, Goudas L, Lawrence D, et al. Management of cancer symptoms: pain, depressionand fatigue. Evidence Report/technology Assessment Number 61.Prepared by the New EnglandMedical Center Evidence-Based Practice Center under Contract No 290-97-0019).AHRQ Publication No. 02-E032. Rockville,MD:Agence for Healthcare Research and Quality;2002.204. Ford S, Fallowfield L, Lewis S. Can oncologists detect distress in their out-patients and howsatisfied are they with their performance during bad news consultations? Br J Cancer.1994;70(4):767-70.205. Chochinov HM, Wilson KG, Enns M, Lander S. «Are you depressed?» Screening for depressionin the terminally ill. Am J Psychiatry. 1997;154(5):674-6.206. Chochinov HM, Wilson KG, Enns M, Mowchun N, Lander S, Levitt M, et al. Desire for deathin the terminally ill. Am J Psychiatry. 1995;152(8):1185-91.207. Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK. The treatment of depression incancer patients: a systematic review. Support Care Cancer. 2007;15(2):123-36.208. Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. AmericanJournal of Hospice and Palliative Medicine. 2006;23(1):35-40.209. Wilson KG. Diagnosis and management of depression in Pallaitive care. In: Chochinov HM,Breitbart W, editors. Handbook of psychiatry in palliative medicine.New York: Oxford UniversityPress; 2000. p. 25-44.210. Hem E, Loge JH, Haldorsen T, Ekeberg O. Suicide risk in cancer patients from 1960 to 1999.J Clin Oncol. 2004;22(20):4209-16.298 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS